2023 annual financial data
Recursion Pharmaceuticals 2023 Operating margin
Recursion Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -797.84%.
Operating income was -350,060,000 USD and net income was -328,066,000 USD.
Operating cash flow was -287,780,000 USD.
Get free Recursion Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 43,876,000 USD
- Operating income
- -350,060,000 USD
- Net income
- -328,066,000 USD
- Operating cash flow
- -287,780,000 USD